Evaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Been Treated for Cancer
EQUICAP
1 other identifier
interventional
10
1 country
1
Brief Summary
This is a category 2 human research study (RIPH), interventional, single-center, prospective, open-label. The primary objective of this study is to qualitatively assess the effects of equicoaching on social reintegration in young adults who have been treated for cancer. The secondary objectives are to evaluate the contribution of equicoaching to:
- 1.Self-confidence;
- 2.Well-being
- 3.Quality of life Satisfaction with equicoaching will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2025
CompletedStudy Start
First participant enrolled
April 5, 2026
CompletedFirst Posted
Study publicly available on registry
April 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
April 13, 2026
April 1, 2026
6 months
December 2, 2025
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
social reintegration
Social reintegration will be assessed using a qualitative comparative analysis of two individual semi-structured interviews conducted at baseline and six months after the intervention. Interview topics will include illness trajectory, social and family relationships, level of autonomy and independence, ability to plan for the future, social participation, and participants' perceptions of the equicoaching intervention. All interviews will be audio-recorded, transcribed verbatim, and analyzed using thematic analysis with NVivo software to identify changes in themes and subthemes over time.
Inclusion and month 6
Secondary Outcomes (3)
Self-confidence
Inclusion and month 6
Well-being
Inclusion and month 6
emotional functioning subscale of Quality of life
Inclusion and month 6
Study Arms (1)
intervention EQUICAP
EXPERIMENTALInterventions
An initial individual interview will be organized with each participant to discuss their experience of the disease, their social relationships, their leisure activities, their relationship with horses, and their relationship with sports, exploring their experiences and practices in physical activities. Questionnaires to assess quality of life, well-being, and self-confidence will be completed during this interview. This will be followed by equicoaching. This intervention will be carried out by two qualified professionals over a period of six months and will consist of six monthly group sessions combined with individual follow-up. This will be followed by equicoaching. This intervention will be carried out by two qualified professionals over a period of six months and will consist of six monthly group sessions combined with monthly individual follow-up via videoconference. The various group sessions will address different topics. After each group session, the AJAs will have individual i
Eligibility Criteria
You may qualify if:
- Have been treated for a malignant oncological or hematological condition.
- Be between 15 and 25 years of age at the time of cancer diagnosis. This age range corresponds to that chosen by the Leon Berard Cancer Center (CLB) and the Institute of Pediatric Hematology and Oncology (IHOPe) for the Adolescents and Young Adults with Cancer (DAJAC) program
- Have been treated at IHOPe/CLB as part of the DAJAC program
- Have completed intensive treatment within the last twelve months.
- Be able to understand, read, and write French
- Be affiliated with a health insurance plan
- Have been informed about the study and have given consent
- For minors:
- All of the above criteria
- Parent/legal guardian informed about the study and having given consent
You may not qualify if:
- Patient deprived of liberty by judicial or administrative decision
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CLB
Lyon, France
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2025
First Posted
April 7, 2026
Study Start
April 5, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04